tweenvest

First Tracks Biotherapeutics, Inc. (NasdaqGS: TRAX)

Health Care · Biotechnology · US

$48.70

-3.62% today · +156.3% 1Y

Public summary
A free snapshot of First Tracks Biotherapeutics, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

First Tracks Biotherapeutics, Inc. (NasdaqGS: TRAX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.05B and employs 104 people.

Over the last twelve months the share price has gained 156.3%, trading between 14.72 and 52.33.

Tweenvest scores First Tracks Biotherapeutics, Inc. across four factors: quality 48/100, value 100/100. Its strongest factor is value.

TRAX price history

Apr 10, 2026 · 23.50Weekly closes 15.96 – 48.70Nov 12, 2026 · 48.70

Key figures

Market cap
$2.05B
Revenue (TTM)
—
P/E
-12.76
EPS
—
Dividend yield
—
Beta (5Y)
—
52-week high
$52.33
52-week low
$14.72
Avg volume (3M)
—
Shares outstanding
42.02M
Employees
104
Next earnings
—

About First Tracks Biotherapeutics, Inc.

First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.

ISIN
US3371851029
Founded
2019
Listed since
Apr 20, 2026
Exchange
Nasdaq Global Select
Currency
USD
CompanyMarket capPriceDay
Beam Therapeutics Inc.NasdaqGS: BEAM$2.09B$20.94-0.33%
Bonesupport Holding AB (publ)OM: BONEX$2.07BSkr323.80+1.63%
PharmaResearch Co., Ltd.KOSDAQ: A214450$2.06B₩265,000.00+2.71%
Biohaven Ltd.NYSE: BHVN$2.06B$13.65+5.81%
Sinocelltech Group LimitedSHSE: 688520$2.03BCN¥28.84-2.80%
Vera Therapeutics, Inc.NasdaqGM: VERA$2.03B$28.10-3.24%
Veracyte, Inc.NasdaqGM: VCYT$2.02B$25.04-2.07%
Aurinia Pharmaceuticals Inc.NasdaqGM: AUPH$2.00B$14.89-1.59%

Browse every Biotechnology company →